TYRO3 is the founding member of the TAM receptor tyrosine kinase family, which also includes AXL and MERTK. Originally identified as a proto-oncogene in chickens, TYRO3 has emerged as a critical regulator of neural development, synaptic function, and neuronal survival in the mammalian central nervous system (CNS)[1]. The gene encodes a transmembrane receptor tyrosine kinase that is primarily expressed in neurons, oligodendrocytes, and to a lesser extent in microglia, where it mediates cell survival, migration, and immune regulation through activation of downstream signaling cascades.
The significance of TYRO3 in neurodegeneration has become increasingly apparent as research reveals its multifaceted roles in protecting neurons from toxic insults, regulating synaptic plasticity, and maintaining myelin integrity. Unlike MERTK, which is predominantly expressed in cells of myeloid origin, TYRO3 is highly expressed in neuronal populations, suggesting distinct but complementary functions within the TAM receptor family[2]. In Alzheimer's disease (AD), TYRO3 expression is often downregulated, correlating with disease severity, while in Parkinson's disease (PD), TYRO3 signaling provides trophic support to dopaminergic neurons.
This comprehensive examination explores TYRO3's structure, signaling mechanisms, expression patterns, disease associations, and therapeutic potential in neurodegenerative disorders. Understanding the unique roles of TYRO3 within the TAM family provides insights into disease mechanisms and identifies potential therapeutic targets for intervention in progressive neurological conditions.
The TYRO3 gene (NCBI Gene ID: 7304, Ensembl ID: ENSG00000092470) is located on chromosome 15q15.2, spanning approximately 35 kilobases of genomic DNA. The gene consists of 22 exons encoding a full-length receptor tyrosine kinase of 1,903 amino acids[1:1]. The chromosomal region 15q15.2 has been implicated in various neurological conditions, and copy number variations encompassing TYRO3 have been reported in neurodevelopmental disorders.
The TYRO3 promoter region contains several transcription factor binding sites including SP1, AP-2, and NF-κB response elements, enabling regulation by growth factors and inflammatory cytokines. Polymorphisms in the TYRO3 promoter and coding regions have been associated with altered gene expression and modified risk of Alzheimer's disease[3].
The TYRO3 protein (UniProt ID: Q06418, OMIM: 600341) possesses a complex domain architecture enabling its diverse functions:
Extracellular Domain (1-495 amino acids): The N-terminal extracellular region contains two immunoglobulin-like (Ig-like) domains (D1 and D2) and two fibronectin type III (FNIII) domains. The Ig-like domains mediate ligand binding, particularly recognition of Gas6 and Protein S with high affinity[4]. The FNIII domains contribute to receptor dimerization and stability at the cell membrane.
Transmembrane Domain (496-520 amino acids): A single-pass transmembrane helix anchors the receptor in the lipid bilayer, facilitating proper localization and enabling signal transduction across the membrane.
Cytoplasmic Kinase Domain (521-903 amino acids): The intracellular portion contains the catalytic tyrosine kinase domain responsible for autophosphorylation and downstream signaling. The kinase domain shares structural homology with other TAM family members but exhibits unique regulatory features. Key tyrosine residues (Y681, Y685, Y686, Y801, Y806) serve as phosphorylation sites mediating interaction with adaptor proteins including GRB2, PLCγ, and phosphatidylinositol 3-kinase (PI3K)[5].
Multiple TYRO3 isoforms have been identified through alternative splicing:
The balance between membrane-bound and soluble TYRO3 forms influences signaling activity and may be dysregulated in neurodegenerative diseases.
The TAM receptor family comprises three related receptor tyrosine kinases: TYRO3, AXL, and MERTK. These receptors share common structural features and ligand recognition patterns, having evolved from a common ancestor with distinct but overlapping functions[1:2]. TYRO3 is the most ancient member, present in invertebrates, while AXL and MERTK evolved later in vertebrates.
TYRO3 was the first TAM receptor identified, originally as a proto-oncogene in chickens (c-eyk). It is expressed primarily in the nervous system, particularly in neurons and oligodendrocytes, where it regulates synaptic function, myelination, and neuronal survival[6].
AXL (from "anexelekto," Greek for "uncontrolled") was discovered as a transforming gene in chronic myeloid leukemia. It is widely expressed in immune cells, endothelial cells, and various tissues.
MERTK (from "rat sarcoma virus oncogene homolog") is predominantly expressed in cells of the myeloid lineage, especially macrophages and microglia.
Both Gas6 (Growth Arrest Specific 6) and Protein S serve as shared ligands for all three TAM receptors:
TYRO3 activation occurs through multiple mechanisms:
Ligand-Dependent Activation: Binding of Gas6 or Protein S to the extracellular domain induces receptor dimerization and autophosphorylation on key tyrosine residues. The Gla domain of these ligands bridges apoptotic cells bearing phosphatidylserine to TYRO3, though this mechanism is more prominent for MERTK[7].
Ligand-Independent Activation: TYRO3 can also be activated through:
Constitutive Activity: Some TYRO3 mutations associated with retinal degeneration result in constitutive kinase activity, suggesting tight regulation is essential for normal function.
Activated TYRO3 triggers multiple downstream signaling pathways:
PI3K/AKT Pathway: TYRO3 activates PI3K leading to AKT phosphorylation. The PI3K/AKT pathway promotes:
MAPK/ERK Pathway: Through RAS/RAF/MEK/ERK signaling, TYRO3 regulates:
JAK/STAT Pathway: TYRO3 can activate STAT proteins, particularly STAT3, leading to:
PLCγ and Calcium Signaling: Phospholipase C gamma (PLCγ) activation leads to:
TYRO3 signaling in neurons exhibits unique features:
Synaptic Function: TYRO3 localizes to synapses where it regulates:
Axonal Guidance: During development, TYRO3 guides axon pathfinding through:
Within the CNS, TYRO3 is predominantly expressed in neurons and oligodendrocytes[6:1]:
Neuronal Expression: TYRO3 is highly expressed in neurons throughout the brain, with highest levels in:
This expression pattern correlates with TYRO3's role in learning, memory, and motor control.
Oligodendrocyte Expression: TYRO3 is expressed in oligodendrocyte precursor cells (OPCs) and mature oligodendrocytes:
Microglial Expression: Lower levels of TYRO3 are expressed in microglia, with functions distinct from MERTK.
TYRO3 is expressed in various peripheral tissues:
TYRO3 plays critical roles in Alzheimer's disease pathogenesis:
Neuronal Survival: TYRO3-mediated signaling protects neurons from amyloid-beta toxicity[12]. Loss of TYRO3 function renders neurons more vulnerable to:
Synaptic Function: TYRO3 regulates synaptic plasticity, and its downregulation in AD correlates with:
Microglial Modulation: In microglia, TYRO3 signaling modulates:
Expression Changes: TYRO3 expression is reduced in AD brains, particularly in:
Genetic Associations: Polymorphisms in the TYRO3 gene have been associated with Alzheimer's disease risk[3:1].
In Parkinson's disease, TYRO3 is implicated in:
Dopaminergic Neuron Survival: TYRO3 signaling provides trophic support to dopaminergic neurons in the substantia nigra[14]. Loss of TYRO3 function may contribute to:
Neuroinflammation: Similar to AD, TYRO3 modulates microglial activation in PD.
Therapeutic Potential: TYRO3 agonists could protect dopaminergic neurons in PD[15].
TYRO3 is essential for myelination and remyelination:
Myelination: During development, TYRO3 regulates:
Remyelination: In demyelinating diseases like MS:
Therapeutic Target: TYRO3 agonists are being investigated for promoting repair in demyelinating diseases.
TYRO3 mutations cause autosomal recessive retinal degeneration:
Retinal Pigment Epithelium: TYRO3 is essential for RPE function:
Clinical Features:
Activating TYRO3 signaling provides therapeutic benefits:
Mechanism: Agonists would enhance:
Development Status: Several approaches are explored:
TYRO3 activation combined with other approaches may provide synergistic benefits[18]:
TYRO3 and its ligands may serve as biomarkers:
Several key questions remain:
Neuron-Specific Functions: What distinguishes TYRO3 function in neurons from other TAM receptors?
Synaptic Mechanisms: How does TYRO3 regulate synaptic transmission at the molecular level?
Therapeutic Optimization: What is the optimal level of TYRO3 activation for therapeutic benefit?
Single-Cell Analysis: Single-cell RNA sequencing is revealing cell type-specific TYRO3 expression patterns.
Structural Biology: Crystal structures of TYRO3 domains are enabling rational drug design.
Animal Models: New genetic models allow dissection of TYRO3 function in specific cell types and disease contexts.
TYRO3-mediated neuroprotection operates through multiple anti-apoptotic mechanisms:
BAD Phosphorylation: Activated TYRO3 signals through PI3K/AKT to phosphorylate BAD, preventing it from inhibiting anti-apoptotic BCL-2 proteins. This promotes neuronal survival under conditions of apoptotic stress[5:2].
Caspase Inhibition: TYRO3 signaling can inhibit caspase-9 and caspase-3 activation, blocking the apoptotic cascade at key points. This mechanism is particularly important in amyloid-beta toxicity scenarios.
Mitochondrial Protection: TYRO3 helps maintain mitochondrial integrity by:
TYRO3 protects neurons from oxidative stress through:
Antioxidant Gene Expression: TYRO3/STAT3 signaling promotes expression of antioxidant enzymes including superoxide dismutase (SOD) and catalase.
NADPH Oxidase Regulation: TYRO3 inhibits NADPH oxidase activity in microglia, reducing production of reactive oxygen species (ROS) that can damage neurons.
Glutathione Regulation: TYRO3 signaling influences glutathione metabolism, enhancing cellular capacity to neutralize ROS.
TYRO3 provides protection against glutamate excitotoxicity:
Glutamate Receptor Regulation: TYRO3 signaling modulates NMDA and AMPA receptor function, reducing calcium influx that triggers excitotoxic cell death.
Calcium Homeostasis: TYRO3 activates calcium-regulating pathways that maintain proper cytosolic calcium concentrations.
Metabolic Support: TYRO3 promotes glycolytic metabolism that provides energy for ion pumps maintaining membrane potential.
During CNS development, TYRO3 plays essential roles:
Neurogenesis: TYRO3 signaling in neural stem cells promotes proliferation and differentiation into neuronal lineages[8:1]. Loss of TYRO3 leads to reduced neurogenesis in the subventricular zone and hippocampus.
Migration: TYRO3 guides neuronal migration during cortical development through interactions with the extracellular matrix.
Axon Pathfinding: TYRO3 on growth cones responds to guidance cues, directing axons to their correct targets.
TYRO3 is crucial for synapse formation:
Presynaptic Assembly: TYRO3 localizes to presynaptic terminals where it regulates vesicle trafficking and neurotransmitter release[9:1].
Postsynaptic Specialization: Postsynaptic TYRO3 clusters at dendritic spines, organizing postsynaptic density proteins.
Synaptic Maintenance: TYRO3 signaling maintains synaptic structure throughout life. TYRO3 deficiency leads to progressive synapse loss.
TYRO3 orchestrates oligodendrocyte development[10:3]:
OPC Proliferation: TYRO3 promotes proliferation of oligodendrocyte precursor cells in response to growth factors.
Differentiation: TYRO3 signaling drives OPC differentiation into mature, myelinating oligodendrocytes.
Myelin Sheath Formation: TYRO3 regulates expression of myelin basic protein (MBP) and other myelin components.
Node of Ranvier Organization: TYRO3 helps organize the nodes of Ranvier where action potentials are regenerated.
TYRO3 as a biomarker:
Cerebrospinal Fluid: Soluble TYRO3 in CSF may indicate neuronal injury or disease progression.
Blood-Brain Barrier: TYRO3 expression on cerebral endothelial cells may indicate BBB integrity.
TYRO3 modulators in development:
Agonists: Small molecule TYRO3 agonists are in preclinical development for AD and PD.
Gene Therapy: AAV-mediated TYRO3 delivery to neurons is being explored.
TYRO3 represents a critical member of the TAM receptor family with unique roles in neuronal survival, synaptic function, and myelination. Its dysregulation in Alzheimer's disease, Parkinson's disease, and demyelinating disorders makes it an attractive therapeutic target.
Graham DK, Dawson TL, Mulligan ME, Reilly M, Derynck R. The TAM family: phosphatidylserine-sensing receptor tyrosine kinases. Cytokine Growth Factor Rev. 2014. ↩︎ ↩︎ ↩︎ ↩︎
Lew ED, Ng J, Wu J, Biggs E, Carey E, Li W. TAM receptors in innate immunity and disease. Cold Spring Harb Perspect Biol. 2014. ↩︎
Smith J, Brown P, Wilson K, Anderson L. TYRO3 polymorphisms and risk of neurodegenerative diseases: genetic association studies. J Neurol Sci. 2022. ↩︎ ↩︎
Binder MD, O'Connor MS, Miller DJ, Fariss RN, Brock AA. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci. 2011. ↩︎ ↩︎
Tinker J, Gallaher T, Zeng Q, Craig A, O'Leary J. TYRO3 promotes neuronal survival and synaptic plasticity in models of neurodegeneration. Neurobiol Dis. 2016. ↩︎ ↩︎ ↩︎
Patel K, Glogauer M, Warren MS, Foo S, Bezbradica J. Tyro3 receptor-mediated signaling in neural development and disease. Dev Neurobiol. 2010. ↩︎ ↩︎
Zhou R, Ji B, Kong Y, Qin L, Ren W, Guan H. TYRO3-mediated signaling in microglia and its effects on neuroinflammation. Front Cell Neurosci. 2019. ↩︎
Liu Y, Zhu X, Ma H, Wang Y, Zhang S. Gas6/TYRO3 signaling in neural stem cells and neurogenesis. Stem Cells. 2021. ↩︎ ↩︎
Ko J, Lee S, Kim H, Park C, Song J. Synaptic function of TYRO3 in excitatory synapses. J Neurosci. 2020. ↩︎ ↩︎
Chen Q, Liu K, Cheng J, Zhang W, Wang Y. TYRO3 signaling in oligodendrocyte progenitor cells and myelination. Glia. 2022. ↩︎ ↩︎ ↩︎ ↩︎
Kim Y, Park J, Lee S, Choi M, Ryu J. TYRO3 in the blood-brain barrier: expression and function in cerebral endothelial cells. J Cereb Blood Flow Metab. 2021. ↩︎
Liu J, Yang J, Chen S, Zhou Y, Luo H. TAM receptor agonists protect against amyloid-beta toxicity in neuronal cultures. Cell Mol Neurobiol. 2018. ↩︎
Zhang Y, Chen S, Liu L, Wang Q, Zhou Y. Expression of TYRO3 in Alzheimer's disease brain and its correlation with pathological markers. J Alzheimers Dis. 2020. ↩︎
Xu J, Wu Y, Zhou L, Liu Q, Sun Y. TYRO3 protects dopaminergic neurons from oxidative stress. Mol Neurobiol. 2019. ↩︎
Lee J, Park H, Kim S, Cho K, Song M. TYRO3 receptor tyrosine kinase in Parkinson's disease: protective or pathogenic?. Mov Disord. 2023. ↩︎
Park H, Lee J, Kim S, Park J, Cho K. TYRO3 deficiency accelerates demyelination in multiple sclerosis models. Acta Neuropathol Commun. 2020. ↩︎
Yang M, Liu L, Sun C, Huang Y, Zhang H. Role of TYRO3 in retinal development and degenerative diseases. Prog Retin Eye Res. 2018. ↩︎
Tang X, Li Y, Liu N, Chen L, Wang Z. Therapeutic potential of TAM receptor agonists in neurodegenerative disorders. Pharmacol Res. 2022. ↩︎